EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Effect of Zolpidem on sleep efficiency and heart rate during daytime nap

B Sinha, CT Yadav

Indian Journal of Aerospace Medicine · 2020

DOI: 10.25259/ijasm_10_2019 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Zolpidem is a non-benzodiazepine and a type-A gamma-aminobutyric acid (GABA) receptor agonist of the imidazopyridine class of drugs which acts as a short-acting sedative and hypnotic. It induces sleep by augmenting its effect in the central nervous system, by binding to GABAA receptor. The drug has been approved for use in USAF and others to induce sleep after extended duration combat mission. Studies are rare where the impact of drug on daytime nap has been studied. In extended duration operation, necessity of inducing sleep to the combatant after the mission is extremely important and unequivocal. The present study was undertaken to observe the impact of Zolpidem on sleep efficiency (SE) and autonomic heart rate (HR) response during short-term daytime nap. Material and Methods: In a double-blind repeated measure, randomly ordered design, 20 healthy male volunteers were evaluated for SE and HR during daytime nap after administering two different doses of Zolpidem. The study protocol involved the analysis of SE using polysomnographic recordings. The participants were advised to report to their normal place of work and do only routine works not involving strenuous activities. They were advised to report to the sleep laboratory at 1200 h. Three different sessions were carried out on each participant, keeping a gap of 72 h between two sessions. The participants were allowed to sleep in the sleep laboratory in a thermoneutral and sound-attenuated condition. They were permitted to sleep ad libitum . The participants were tested without drug in one of the sessions and during other two sessions, the participants were given 5 mg or 10 mg Zolpidem. One-way ANOVA was carried out to analyze the data and Tukey honestly significant difference post hoc test was employed to compare between the three conditions. Results: Total sleep time (TST) increased significantly from 120.1 ± 38.34 min at baseline to 232.3 ± 41.30 min ( P < 0.001) after 5 mg Zolpidem and 249.2 ± 26.92 min after 10 mg Zolpidem ( P < 0.001). SE (calculated by dividing the amount of time spent asleep [in min] by the total amount of time in bed [in min]) increased significantly from baseline to post-Zolpidem administration (79 ± 11.52%, 91.5 ± 3.61%, and 94.5 ± 1.59%) ( P < 0.001 as compared from baseline data). Average HR (AHR) decreased during sleep from baseline (88.0 ± 8.68 bpm) to 5 mg Zolpidem administration (78.2 ± 7.42) ( P < 0.001) and to 10 mg Zolpidem administration (79.2 ± 7.33 bpm) ( P < 0.01). Conclusion: Zolpidem administration caused an increase in TST and SE and a decrease in AHR during daytime nap.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →